Cargando…
Is ERCC1 a prognostic biomarker for urothelial cancer following radical cystectomy? A long-term analysis
INTRODUCTION: Excision repair cross-complementation 1 protein (ERCC1) plays a vital role in cancer cells enabling DNA repair via nucleotide excision repair. Thus, we hypothesized whether expression of this protein may be utilized as a prognostic marker in patients after radical cystectomy. MATERIAL...
Autores principales: | Obarzanowski, Mateusz, Kopczynski, Janusz, Jaskulski, Jaroslaw, Domagala, Antoni, Macek, Pawel, Gozdz, Stanislaw, Salagierski, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552925/ https://www.ncbi.nlm.nih.gov/pubmed/34729224 http://dx.doi.org/10.5173/ceju.2021.0043 |
Ejemplares similares
-
The Comprehensive Complication Index. Proposed modification to improve estimates of perioperative morbidity after radical cystectomy. A pilot study
por: Zaręba, Anita, et al.
Publicado: (2021) -
Lymph node dissection during laparoscopic (LRC) and open (ORC) radical cystectomy due to muscle invasive bladder urothelial cancer (pT2-3, TCC)
por: Chlosta, Piotr, et al.
Publicado: (2011) -
Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
por: Matuszczak, Milena, et al.
Publicado: (2020) -
Prognostic value of vascular mimicry in patients with urothelial carcinoma of the bladder after radical cystectomy
por: Zhou, Lin, et al.
Publicado: (2016) -
The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy
por: Ku, J H, et al.
Publicado: (2015)